Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic Treatment Naive Subjects Infected With Hepatitis B Virus
Conditions: Hepatitis B; HBV; Hepatitis B, Chronic Interventions: Drug: Inarigivir soproxil; Drug: Tenofovir alafenamide fumarate (TAF) Sponsors: Spring Bank Pharmaceuticals, Inc.; PRA Health Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials